1. The strategic question, in one sentence
The honest question isn’t “which AI support agent is better” — it’s whether you believe the future of support is software you operate or an outcome you buy, because Decagon and Crescendo have made opposite bets and priced themselves accordingly.
2. Side-by-side
| Category | Decagon | Crescendo |
|---|---|---|
| Last round | Series D — $250M, Jan 28 2026 | ~$50M total financing, General Catalyst-led (2024) |
| Valuation | ~$4.5B (tripled at Series D) | ~$500M post-round |
| Total raised | ~$481M across six rounds | ~$50M |
| Founded | 2023 | 2023 |
| Flagship product | Autonomous AI concierge — agentic resolution across chat and voice | AI-native contact center + ~3,000 human CX agents (via PartnerHero) |
| Pricing | Platform/usage-based; you operate the agent | Outcome-based — from ~$1.25/resolution; Total Outcomes Guarantee |
| Best-fit GTM use | High-volume, clean-knowledge deflection at near-zero marginal cost | Guaranteed-outcome managed CX, including messy/complex queues |
3. Where they overlap, where they don’t
On the surface, both sell the same promise: stop hiring linearly to serve more customers. Both founded in 2023, both ride the same wave of agentic LLMs, both will show up on the same RFP shortlist when a VP of Support is told to “do something about AI.” That’s the overlap — and it’s mostly the pitch deck, not the product.
Underneath, they diverge almost completely. Decagon sells software. It hands you an autonomous agent and the controls to run it — and the implicit assumption that you, the buyer, own the resolution rate, the escalation logic, and the blast radius when the model is confidently wrong. The replace-the-human thesis is literal: the goal is to drive human touches toward zero. That’s why ~$481M of capital and a $4.5B valuation make sense — Decagon is priced like an infrastructure company whose marginal cost per ticket trends to nothing.
Crescendo sells an outcome. The product is the contract: pay per resolution, and the vendor — not you — absorbs whatever mix of AI and human labor it takes to hit the number. The 2024 PartnerHero acquisition is the tell. Crescendo deliberately bought ~3,000 human CX professionals, which a pure-software company would never do. It’s services-inflected by design, because the blended model needs humans on the floor to backstop the AI and to honor the Total Outcomes Guarantee. That’s also why the valuation is an order of magnitude lower — the market prices managed services, even AI-augmented ones, on services multiples, not software multiples.
4. The buyer split is sharper than the product split
Here’s the part most comparisons miss: the product gap is real, but the buyer gap is sharper. These two companies are optimized for two different people who both happen to sit in the support org.
Decagon’s natural buyer is a platform-minded operator — someone who already thinks in deflection rates, containment, and tooling, and who has (or wants) an internal AI-ops capability. They want the controls, they want to own the curve, and they accept that owning the agent means owning its failures. For that buyer, paying per resolution feels like renting forever; they’d rather capitalize the platform and push marginal cost to zero. Decagon’s enterprise traction reflects exactly this: large operators with the volume to justify operating the agent themselves.
Crescendo’s natural buyer wants the opposite arrangement. They don’t want to build an AI-ops team, tune prompts, or explain to the board why the bot mishandled a refund. They want a guaranteed CSAT number and a single vendor accountable for it. For them, outcome-based pricing isn’t a tax — it’s risk transfer, and the guarantee is the product. This is the buyer replacing a BPO, not the buyer building an internal platform. The “human + AI” framing isn’t a hedge against weak AI; it’s a recognition that some queues — emotional, ambiguous, high-stakes — punish full deflection, and that a human safety net is what makes the outcome guaranteeable.
So the real question a buyer should ask isn’t “whose AI is smarter.” It’s “do I want to operate an agent or buy a result?” Answer that, and the vendor chooses itself.
5. The 18-month threats
Decagon
Decagon’s threat is from above. Sierra — at a $15.8B valuation after its $950M Series C in May 2026 — is the better-capitalized version of the same software thesis, and it’s coming for the same enterprise logos. Decagon’s $4.5B is a strong number, but it sits in the awkward middle: too expensive to be the scrappy challenger, not yet large enough to out-spend Sierra on enterprise GTM. The second threat is commoditization — as foundation models get better at tool-use and resolution out of the box, the moat shifts from “can the agent resolve” to integrations, governance, and trust. Decagon has to keep proving that operating its agent is materially better than operating a thinner wrapper on a frontier model.
Crescendo
Crescendo’s threat is from below — its own cost structure. Outcome-based pricing with a human backstop is only durable if AI keeps absorbing more of the volume; if model improvements lag, Crescendo is left carrying a 3,000-person services org on services economics while competitors run leaner. The structural question is margin, not growth. The second threat is the squeeze: if Decagon and Sierra push autonomous resolution good enough that the human layer becomes the exception rather than the safety net, Crescendo’s differentiation — the guarantee — gets cheaper to replicate, and its services-heavy P&L looks like a liability rather than a feature. Its defense is that the messy, judgment-heavy tail of support is stickier and harder to fully automate than the software camp admits — and on that bet, the next 18 months are the test.
6. Verdict
This isn’t a head-to-head — it’s a fork. Decagon is the right call for the operator with clean knowledge, high volume, and the will to run an autonomous agent and capture near-zero marginal cost; it’s priced and built for buyers who want to own the curve. Crescendo is the right call for the leader who wants a guaranteed outcome, a vendor on the hook for CSAT, and no AI-ops headcount — especially across messy, multilingual, judgment-heavy queues a pure-deflection bot will fumble. The uncomfortable truth is that the better AI gets, the more Decagon’s thesis compounds and the harder Crescendo has to work to keep its human layer from looking like cost instead of insurance. If you’re betting on where the puck is going, Decagon is the more aligned bet — but if you need the outcome guaranteed this quarter and don’t want to operate anything, Crescendo is the honest answer, and the cheaper entry point. Decide which kind of buyer you are first; the logo follows.